AbbVie Inc. Accounts and Other Receivables, Net, Current
AbbVie Inc. (ABBV) had Accounts and Other Receivables, Net, Current of $5.09 billion as of 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Balance Sheet › Assets › Receivables, Net, Current
us-gaap:AccountsAndOtherReceivablesNetCurrent · last filed 2018-02-16
- 2017-12-31: Accounts and Other Receivables, Net, Current $5.09B.
- 2016-12-31: Accounts and Other Receivables, Net, Current $4.76B.
- 2015-12-31: Accounts and Other Receivables, Net, Current $4.73B.
- 2015-09-30: Accounts and Other Receivables, Net, Current $4.57B.
| Period end | Accounts and Other Receivables, Net, Current |
|---|---|
| 2017-12-31 | $5.09B 10-K · filed 2018-02-16 |
| 2016-12-31 | $4.76B 10-K · filed 2018-02-16 |
| 2015-12-31 | $4.73B 10-K · filed 2017-02-17 |
| 2015-09-30 | $4.57B 10-Q · filed 2015-11-06 |
| 2015-06-30 | $4.37B 10-Q · filed 2015-08-07 |
| 2015-03-31 | $4.21B 10-Q · filed 2015-05-08 |
| 2014-12-31 | $3.73B 10-K · filed 2016-02-19 |
| 2014-09-30 | $3.59B 10-Q · filed 2014-11-07 |
| 2014-06-30 | $3.68B 10-Q · filed 2014-08-07 |
| 2014-03-31 | $3.65B 10-Q · filed 2014-05-09 |
| 2013-12-31 | $3.85B 10-K · filed 2015-02-20 |
| 2013-09-30 | $3.80B 10-Q · filed 2013-11-12 |
| 2013-06-30 | $3.75B 10-Q · filed 2013-08-09 |
| 2013-03-31 | $4.30B 10-Q · filed 2013-05-08 |
| 2012-12-31 | $4.30B 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |